BIO vs FA · rev $2.58B vs P/E 318, rev $860.2M
BIO (BIO) versus First Advantage Corp (FA) — a side-by-side from cached financials, not a winner call.
BIO (BIO) common stock.
First Advantage Corp (FA) is a specialty business services company listed on US.
Latest reported BIO revenue for 2025-12-31 was $2.58B. Net income was $759.9M. Revenue was up 0.7% from 2024-12-31 to 2025-12-31. BIO currently screens at market cap $0.
Latest reported FA revenue for 2024-12-31 was $860.2M. Net income was -$110.3M. Revenue was up 12.6% from 2023-12-31 to 2024-12-31. FA currently screens at market cap $2.72B and trailing P/E 317.6.
BIO currently screens at market cap $0. FA currently screens at market cap $2.72B and trailing P/E 317.6.
Not investment advice. Open the BIO and FA stock pages for the full models.
Not investment advice.